- Ventafridda V, Ripamonte C, Sbanotto A, De Conno F. Mouth care. In: Doyle D, Hanks GWC, MacDonald N. (eds) Oxford Textbook of Palliative Medicine, 2nd edn. New York: Oxford University Press, 1998;691–9.
- Sweeney MP, Bagg J, Baxter WP, Aitchison TC. Oral disease in terminally ill cancer patients with xerostomia. Oral Oncol 1998; 34: 123–6.
- Rand HR, Kramer B, Johnson AC. Cancer chemotherapy associated symptomatic stomatitis: role of herpes simplex virus. Cancer 1986; 50: 1262.
- Bergmann OJ, Mogensen SC, Ellegard J. Herpes simplex virus and intraoral lesions in immunocompromised patients with haematological malignancy. Eur J Clin Microbiol Infect Dis 1990; 9: 184–90.
- Twycross RG, Lack SA. Control of alimentary symptoms in far advanced cancer. Mouth 1986; 2: 12–39.
- Saral R. Oral complications of cancer therapies. Management of acute viral infections. NCI Monog 1990; 9: 107–10.
- Leming PD, Martin SE, Zwelling LA. Atypical herpes simplex infection in a patient with Hodgkin’s disease. Cancer 1984; 54: 3043–7.
- Scott DA, Coulter WA, Biagioni PA, O’Neill HO, Lamey PJ. Detection of herpes simplex virus type I shedding in the oral cavity by polymerase chain reaction and enzyme-linked immunosorbent assay at the prodromal stage of recrudescent herpes labialis. J Oral Pathol Med 1997; 26: 305–9.
- Hamuy R, Berman B. Treatment of herpes simplex virus infections with topical antiviral agents. Eur J Dermatol 1998; 8: 310–9.
- Biagioni PA, Lamey PJ. Acyclovir cream prevents clinical and thermographic progression of recrudescent herpes labialis beyond the prodromal stage. Acta Dermatovenereol 1998; 78: 46–7.
- Spruance SL, Rea TL, Thoming C, Tucker R, Saltzman R, Boon R. Penciclovir cream for the treatment of herpes simplex labialis. JAMA 1997; 277: 1374–9.
- Van Vloten WA, Swart RN, Pot F. Topical acyclovir therapy in patients with recurrent orofacial herpes simplex infections. J Antimicrob Chemother 1983;Suppl B:89–93.
- Whitley RJ, Levin M, Barton N, Hershey BJ, Davis G, Keeney RE et al. Infections caused by herpes simplex virus in the immunocompromised host: natural history and topical acyclovir therapy. J Infect Dis 1984; 150: 323–9.
- Whitley R, Barton N, Collins E, Whelchel J, Diethelm AG. Mucocutaneous herpes simplex virus infections in immunocompromised patients. A model for evaluation of topical antiviral agents. Am J Med 1982; 73: 236–40.
- Lavelle CL. Acyclovir: is it an effective virostatic agent for orofacial infections? J Oral Pathol Med 1993; 22: 391–401.
- Worrall G. Evidence for efficacy of topical acyclovir in recurrent herpes labialis is weak. BMJ 1996; 313: 46.
- Tang IT, Shepp DH. Herpes simplex virus infection in cancer patients: prevention and treatment. Oncology 1992; 6: 101–6.
- Epstein JB, Scully C. Herpes simplex virus in immunocompromised patients: growing evidence of drug resistance. Oral Surg Oral Med Oral Pathol 1991; 72: 47–50.
- Choose new content alerts to be informed about new research of interest to you
- Easy remote access to your institution's subscriptions on any device, from any location
- Save your searches and schedule alerts to send you new results
- Export your search results into a .csv file to support your research